Skip to main content
OpenTrials

Clinical trial condition

Macular Degeneration

Explore clinical trials studying Macular Degeneration. Study availability and eligibility vary by location and protocol.

392 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Macular Degeneration trial results

Recruiting

Evaluating the Safety and Tolerability of Orally Administered DF-003 in ROSAH Syndrome Patients

NCT06395285

Conditions
Cone-Rod Dystrophies, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, +10 more
Locations
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Duke Eye Center - Duke University Hospital Durham, North Carolina, United States
  • John A. Moran Eye Center - University of Utah Health Salt Lake City, Utah, United States
  • Save Sight Institute - University of Sydney Eye Hospital Sydney, New South Wales, Australia
View Trial Details
Recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK

NCT06990399

Conditions
Eye Diseases, Macular Degeneration, Macular Edema, +3 more
Locations
  • AZ Retina & Vitreous Consultants Phoenix, Arizona, United States
  • Research Network Arizona Scottsdale, Arizona, United States
  • California Retina Consultants (Bakersfield) Bakersfield, California, United States
  • Global Research Management, Inc. Glendale, California, United States
View all 56 locations
View Trial Details
Recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE

NCT06996080

Conditions
Eye Diseases, Macular Degeneration, Macular Edema, +3 more
Locations
  • AZ Retina & Vitreous Consultants Phoenix, Arizona, United States
  • Research Network Arizona Scottsdale, Arizona, United States
  • California Retina Consultants (Bakersfield) Bakersfield, California, United States
  • Global Research Management, Inc. Glendale, California, United States
View all 56 locations
View Trial Details
Recruiting

Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER).

NCT04663750

Conditions
Eye Diseases, Macular Degeneration, Macular Degeneration, Wet, +4 more
Locations
  • University of Bonn Bonn, Germany
  • University Medical Center Hamburg Eppendorf Hamburg, Germany
  • Ludwig Maximilians-University München München, Germany
  • Augenzentrum am St. Franziskus-Hospital Münster Münster, Germany
View all 36 locations
View Trial Details
Recruiting

Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease

NCT07439887

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +5 more
Locations
  • RayTx Clinical Site Bakersfield, California, United States
  • UPMC Vision Institute Pittsburgh, Pennsylvania, United States
  • RayTx Clinical Site Bellaire, Texas, United States
View Trial Details

Related conditions